Table 2.
Treatment | Siderophore | ACC (α ketobutyrate/mg protein/h) | HCN | Confrontation assay (% inhibition) | |||
---|---|---|---|---|---|---|---|
% Siderophore units | HQ Test | R. solani | S. rolfsii | ||||
1 | P5 | 33.54bcdefg ± 10.21 | – | 1.48 ± 0.23 | – | 38.90abc ± 11.10 | 19.45ef ± 2.75 |
2 | P6 | 45.1abcde ± 1.77 | *** | 2.9 ± 0.15 | – | 51.10ab ± 1.10 | 35.55abcde ± 6.65 |
3 | P11 | 28.67cdefgh ± 11.97 | – | 13.11 ± 1.29 | – | 34.45abc ± 12.75 | 27.25bcdef ± 9.45 |
4 | P67 | 9.48gh ± 6.15 | – | 10.51 ± 0.06 | – | 37.25abc ± 9.45 | 27.80bcdef ± 0.05 |
5 | P72 | 17.40fgh ± 10.74 | – | 4.42 ± 0.07 | – | 42.20abc ± 3.30 | 26.10cdef ± 6.60 |
6 | P76 | 54.79ab ± 1.46 | * | 16.24 ± 0.05 | +++ | 49.45ab ± 7.25 | 49.40a ± 5.00 |
7 | P85 | 51.15abcd ± 14.48 | *** | nd | – | 40.00abc ± 6.70 | 43.35abc ± 4.45 |
8 | P99 | 15.93gh ± 5.93 | – | 19.75 ± 0.21 | – | 29.45bcd ± 7.25 | 33.85abcde ± 8.35 |
9 | P124 | 11.98gh ± 3.65 | * | 20.37 ± 0.25 | +++ | 43.85abc ± 11.65 | 35.00abcde ± 7.20 |
10 | P126 | 46.77abcde ± 0.10 | – | 31.05 ± 0.046 | – | 36.10abc ± 8.30 | 17.21ef ± 15.0 |
11 | P129 | 49.9abcd ± 3.23 | * | 23.94 ± 0.32 | – | 42.20abc ± 2.20 | 8.33f ± 2.78 |
12 | P141 | 56.46ab ± 0.21 | * | 40.87 ± 0.08 | – | 40.00abc ± 6.70 | 23.30cdef ± 7.80 |
13 | P143 | 45abcde ± 5.00 | * | 16.27 ± 0.14 | – | 42.75abc ± 1.65 | 27.80bcdef ± 11.10 |
14 | P151 | 45abcde ± 5.00 | * | 28.64 ± 0.26 | – | 50.00ab ± 0.05 | 21.65def ± 10.55 |
15 | P161 | 12.71gh ± 6.05 | – | 25.61 ± 0.05 | – | 22.20cd ± 0.05 | 10.00f ± 1.10 |
16 | P167 | 7.92h ± 4.49 | – | nd | – | 35.00abc ± 5.00 | 41.65abcd ± 2.75 |
17 | P176 | 61.36a ± 1.98 | * | 25.89 ± 0.21 | – | 52.75ab ± 8.35 | 32.20abcde ± 7.70 |
18 | P179 | 21.56efgh ± 12.81 | – | 21.61 ± 0.27 | +++ | 4.44d ± 2.22 | 10.01f ± 7.79 |
19 | P201 | 52.82abc ± 12.82 | * | 25.02 ± 0.37 | – | 55.00a ± 5.00 | 25.00cdef ± 7.20 |
20 | P205 | 17.39fgh ± 10.73 | – | 28.56 ± 0.02 | – | 4.44d ± 2.22 | 22.20def ± 0.05 |
21 | P216 | 41.98abcdef ± 1.35 | ** | nd | – | 44.45abc ± 5.55 | 47.20ab ± 8.30 |
22 | P233 | 62.92a ± 0.42 | *** | 26.75 ± 0.05 | – | 45.55abc ± 12.55 | 32.80abcde ± 6.10 |
23 | P247 | 33.34bcdefg ± 16.67 | ** | 32.61 ± 1.22 | – | 41.65abc ± 8.35 | 22.80def ± 5.00 |
24 | P248 | 26.875defgh ± 16.88 | ** | 23.55 ± 0.272 | – | 36.65abc ± 25.55 | 47.20ab ± 2.80 |
Max. | 62.915a ± 0.42 | 55.00a ± 5.00 | 49.40a ± 5.00 | ||||
Min. | 9.48gh ± 6.15 | 4.44d ± 2.22 | 8.33f ± 2.78 | ||||
CD (0.01%) | 34.198 | – | 27.70 | ||||
CD (0.05%) | 25.230 | 25.39 | 20.45 | ||||
CV | 4.247 | 32.08 | 34.60 | ||||
Fcal | 2.17 | 2.03 |
Values are average of three replications; values after ± represents standard error; CV, coefficient of variance; CD, critical difference; Values are significant at 1 and 5% levels; As per Duncan’s grouping means with the same letter are not significantly different; HQ hydroxyquinoline test; *** Luxuriant/high growth; ** medium growth; * low growth; –, no growth; nd, not determined